Your search returned over 250 studies. The top 250 studies are being displayed. Please use additional keywords or decrease the search distance. Get alerts for new studies
- A Study of Pertuzumab in Addition to Chemotherapy and Herceptin (Trastuzumab) as Adjuvant Therapy in Patients With HER2-Positive Primary Breast Cancer
Conditions: Breast Cancer
Location: Everett, California
- A Study With Aleglitazar in Patients With a Recent Acute Coronary Syndrome and Type 2 Diabetes Mellitus
Conditions: Diabetes Mellitus, Type 2
Location: Everett, California
- Study of Total Body Irradiation in Combination With Allogeneic Peripheral Blood Stem Cell or Bone Marrow Transplantation Followed By Cyclosporine and
Conditions: HIV Infections
Location: Seattle, Washington
- Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma
Conditions: Neuroblastoma
Location: Seattle, Washington
- Genetic Study of Cancer Risk and Gene Identification in Patients With Inherited Bone Marrow Disorders and Their Families
Conditions: Cancer
Location: Seattle, Washington
- Genetic Study of Cancer Risk and Gene Identification in Patients With Inherited Bone Marrow Disorders and Their Families
Conditions: Cancer
Location: Seattle, Washington
- Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma
Conditions: Sarcoma
Location: Seattle, Washington
- Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metas
Conditions: Metastatic Cancer - Prostate Cancer
Location: Bellingham, Washington
- Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metas
Conditions: Metastatic Cancer - Prostate Cancer
Location: Bremerton, Washington
- Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metas
Conditions: Metastatic Cancer - Prostate Cancer
Location: Kirkland, Washington
- Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metas
Conditions: Metastatic Cancer - Prostate Cancer
Location: Seattle, Washington
- Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metas
Conditions: Metastatic Cancer - Prostate Cancer
Location: Seattle, Washington
- Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metas
Conditions: Metastatic Cancer - Prostate Cancer
Location: Seattle, Washington
- Study of Late-Occurring Complications in Childhood Cancer Survivors
Conditions: Cancer
Location: Seattle, Washington
- Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastom
Conditions: Brain and Central Nervous System Tumors
Location: Seattle, Washington
- Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallo
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Peritoneal Cavity Cancer
Location: Seattle, Washington
- Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallo
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Peritoneal Cavity Cancer
Location: Seattle, Washington
- Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallo
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Peritoneal Cavity Cancer
Location: Seattle, Washington
- Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallo
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Peritoneal Cavity Cancer
Location: Seattle, Washington
- Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallo
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Peritoneal Cavity Cancer
Location: Seattle, Washington
- Iodine I 131 Tositumomab and Fludarabine Phosphate in Treating Older Patients Who Are Undergoing an Autologous or Syngeneic Stem Cell Transplant for R
Conditions: Mucosa-Associated Lymphoid Tissue Lymphoma - Monocytoid B-cell Lymphoma - Recurrent Adult Burkitt's Lymphoma - Recurrent Adult Diffuse Large Cell Lymphoma - Recurrent Adult Diffuse Mixed Cell Lymphoma - Recurrent Adult Diffuse Small Cleaved Cell Lymphoma
Location: Seattle, Washington
- Radiologic Evaluation and Breast Density (READ)
Conditions: Breast Cancer
Location: Seattle, Washington
- Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Conditions: Lymphoma
Location: Bellingham, Washington
- Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Conditions: Lymphoma
Location: Bremerton, Washington
- Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Conditions: Lymphoma
Location: Mt. Vernon, Washington
- Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Conditions: Lymphoma
Location: Poulsbo, Washington
- Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Conditions: Lymphoma
Location: Seattle, Washington
- Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Conditions: Lymphoma
Location: Seattle, Washington
- Removal Versus Retention of Cerclage in Preterm Premature Rupture of Membranes (PPROM)
Conditions: Fetal Membranes, Premature Rupture
Location: Kirkland, Washington
- Intermittent Hormone Therapy in Men With Localized Prostate Cancer After Radiation Therapy or Radical Prostatectomy
Conditions: Prostate Cancer
Location: Seattle, Washington
- SMART: Somatotrophics, Memory, and Aging Research Trial
Conditions: Aging - Mild Cognitive Impairment
Location: Seattle, Washington
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Conditions: Colorectal Cancer
Location: Bellingham, Washington
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Conditions: Colorectal Cancer
Location: Bremerton, Washington
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Conditions: Colorectal Cancer
Location: Mt. Vernon, Washington
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Conditions: Colorectal Cancer
Location: Poulsbo, Washington
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Conditions: Colorectal Cancer
Location: Seattle, Washington
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Conditions: Colorectal Cancer
Location: Seattle, Washington
- Study to Assess Compliance With Long-Term Mercaptopurine Treatment in Young Patients With Acute Lymphoblastic Leukemia in Remission
Conditions: Leukemia
Location: Seattle, Washington
- Familial Barrett's Esophagus
Conditions: Barrett's Esophagus - Esophageal Neoplasm
Location: Seattle, Washington
- Fenretinide LXS in Treating Patients With Recurrent, Refractory, or Persistent Neuroblastoma
Conditions: Neuroblastoma
Location: Seattle, Washington
- Effects of the Combination of Bosentan and Sildenafil Versus Sildenafil Monotherapy on Pulmonary Arterial Hypertension (PAH)
Conditions: Pulmonary Hypertension
Location: Seattle, Washington
- Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant
Conditions: Kidney Cancer - Leukemia - Lymphoma - Myelodysplastic Syndromes - Neuroblastoma - Pulmonary Complications - Sarcoma
Location: Seattle, Washington
- Cooperative Huntington's Observational Research Trial
Conditions: Huntington Disease
Location: Kirkland, Washington
- Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors
Conditions: Kidney Cancer
Location: Seattle, Washington
- Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surge
Conditions: Kidney Cancer
Location: Seattle, Washington
- Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
Conditions: Sarcoma
Location: Seattle, Washington
- Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes
Conditions: Leukemia - Myelodysplastic Syndromes
Location: Seattle, Washington
- Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Seattle, Washington
- Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant
Conditions: Graft Versus Host Disease - Leukemia
Location: Seattle, Washington
- Erlotinib and Bevacizumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Bellingham, Washington
- Erlotinib and Bevacizumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Bremerton, Washington
- Erlotinib and Bevacizumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Mt. Vernon, Washington
- Erlotinib and Bevacizumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Poulsbo, Washington
- Erlotinib and Bevacizumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Seattle, Washington
- Erlotinib and Bevacizumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Seattle, Washington
- Erlotinib and Bevacizumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Seattle, Washington
- Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
Conditions: Cognitive/Functional Effects - Leukemia - Long-term Effects Secondary to Cancer Therapy in Children - Neurotoxicity - Psychosocial Effects of Cancer and Its Treatment
Location: Seattle, Washington
- Sibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other Diseases
Conditions: Chronic Myeloproliferative Disorders - Graft Versus Host Disease - Leukemia - Lymphoma - Myelodysplastic Syndromes - Secondary Myelofibrosis
Location: Seattle, Washington
- Exercise and Activities for Independent Living With Mild Cognitive Impairment (MCI)
Conditions: Mild Cognitive Impairment - Dementia
Location: Seattle, Washington
- Role of CYP2B6, CYP3A4, and MDR1 in the Metabolic Clearance of Methadone
Conditions: Substance-Related Disorders
Location: Seattle, Washington
- Effectiveness of an Exercise Program at Improving Heart and Lung Function in People With an Implantable Cardioverter Defibrillator (ICD)
Conditions: Defibrillators, Implantable - Heart Failure, Congestive
Location: Seattle, Washington
- Different Therapies in Treating Infants With Newly Diagnosed Acute Leukemia
Conditions: Leukemia
Location: Seattle, Washington
- Positron Emission Tomography Using Fluoromisonidazole F 18 and Fludeoxyglucose F 18 to Find Oxygen in Tumor Cells of Patients Undergoing Treatment for
Conditions: Cervical Cancer
Location: Seattle, Washington
- Carboplatin and Paclitaxel With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Malignant Tumor of Peritoneum
Location: Bellingham, Washington
- Carboplatin and Paclitaxel With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Malignant Tumor of Peritoneum
Location: Bremerton, Washington
- Carboplatin and Paclitaxel With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Malignant Tumor of Peritoneum
Location: Bremerton, Washington
- Carboplatin and Paclitaxel With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Malignant Tumor of Peritoneum
Location: Everett, Washington
- Carboplatin and Paclitaxel With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Malignant Tumor of Peritoneum
Location: Mount Vernon, Washington
- Carboplatin and Paclitaxel With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Malignant Tumor of Peritoneum
Location: Poulsbo, Washington
- Carboplatin and Paclitaxel With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Malignant Tumor of Peritoneum
Location: Seattle, Washington
- Carboplatin and Paclitaxel With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Malignant Tumor of Peritoneum
Location: Seattle, Washington
- Carboplatin and Paclitaxel With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Malignant Tumor of Peritoneum
Location: Seattle, Washington
- Carboplatin and Paclitaxel With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Malignant Tumor of Peritoneum
Location: Seattle, Washington
- Carboplatin and Paclitaxel With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Malignant Tumor of Peritoneum
Location: Seattle, Washington
- Carboplatin and Paclitaxel With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Malignant Tumor of Peritoneum
Location: Sequim, Washington
- Induction of Clinical Response Using Rifaximin in Crohn's Disease
Conditions: Crohn's Disease
Location: Seattle, Washington
- Safety of Sports for Patients With Implantable Cardioverter-Defibrillators
Conditions: Patients With ICD's Who Are Participating in Sports.
Location: Seattle, Washington
- Host Response to Urinary Tract Infection in Women
Conditions: Urinary Tract Infection
Location: Seattle, Washington
- Intravenous Fenretinide in Treating Young Patients With Recurrent or Resistant Neuroblastoma
Conditions: Neuroblastoma
Location: Seattle, Washington
- SIS Multicenter Study of Duration of Antibiotics for Intraabdominal Infection
Conditions: Peritonitis
Location: Seattle, Washington
- Azacitidine and Gemtuzumab in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
Conditions: Leukemia
Location: Bellingham, Washington
- Azacitidine and Gemtuzumab in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
Conditions: Leukemia
Location: Bremerton, Washington
- Azacitidine and Gemtuzumab in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
Conditions: Leukemia
Location: Mt. Vernon, Washington
- Azacitidine and Gemtuzumab in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
Conditions: Leukemia
Location: Poulsbo, Washington
- Azacitidine and Gemtuzumab in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
Conditions: Leukemia
Location: Seattle, Washington
- Azacitidine and Gemtuzumab in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
Conditions: Leukemia
Location: Seattle, Washington
- Azacitidine and Gemtuzumab in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
Conditions: Leukemia
Location: Seattle, Washington
- Erlotinib With or Without Carboplatin and Paclitaxel in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Bellingham, Washington
- Erlotinib With or Without Carboplatin and Paclitaxel in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Bremerton, Washington
- Erlotinib With or Without Carboplatin and Paclitaxel in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Mt. Vernon, Washington
- Erlotinib With or Without Carboplatin and Paclitaxel in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Poulsbo, Washington
- Erlotinib With or Without Carboplatin and Paclitaxel in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Seattle, Washington
- Erlotinib With or Without Carboplatin and Paclitaxel in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Seattle, Washington
- Erlotinib With or Without Carboplatin and Paclitaxel in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Seattle, Washington
- Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia
Conditions: Leukemia
Location: Seattle, Washington
- Managing Inflammatory Bowel Disease
Conditions: Inflammatory Bowel Disease - Crohn's Disease - Ulcerative Colitis
Location: Seattle, Washington
- Capecitabine and Lapatinib With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB, Stage IIIC, or Stage IV
Conditions: Breast Cancer
Location: Bellingham, Washington
- Capecitabine and Lapatinib With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB, Stage IIIC, or Stage IV
Conditions: Breast Cancer
Location: Bremerton, Washington
- Capecitabine and Lapatinib With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB, Stage IIIC, or Stage IV
Conditions: Breast Cancer
Location: Mt. Vernon, Washington
- Capecitabine and Lapatinib With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB, Stage IIIC, or Stage IV
Conditions: Breast Cancer
Location: Poulsbo, Washington
- Capecitabine and Lapatinib With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB, Stage IIIC, or Stage IV
Conditions: Breast Cancer
Location: Seattle, Washington
- Capecitabine and Lapatinib With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB, Stage IIIC, or Stage IV
Conditions: Breast Cancer
Location: Seattle, Washington
- Telephone Intervention for Caregivers of Persons With Traumatic Brain Injury
Conditions: Brain Injuries
Location: Seattle, Washington
- Non-invasive Test to Detect Intra-amniotic Infection in Women With Preterm Labor and Intact Amniotic Membranes
Conditions: Intra-amniotic Infection
Location: Seattle, Washington
- Using Magnetic Resonance Imaging to Evaluate Carotid Artery Plaque Composition in People Receiving Cholesterol-Lowering Medications (The CPC Study)
Conditions: Coronary Artery Disease - Carotid Artery Diseases - Atherosclerosis
Location: Seattle, Washington
- Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Conditions: Brain and Central Nervous System Tumors - Chronic Myeloproliferative Disorders - Leukemia - Long-term Effects Secondary to Cancer Therapy in Children - Lymphoma - Lymphoproliferative Disorder - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic S
Location: Seattle, Washington
- Evaluation of an Intervention to Increase Colorectal Cancer Screening in Primary Care Clinics
Conditions: Colorectal Cancer
Location: Seattle, Washington
- Safety & Pharmacokinetics Study Of Azacitidine (SC And Oral) In Subjects With MDS, CMML, AML, Lymphoma And Multiple Myeloma
Conditions: Acute Myeloid Leukemia - Myelodysplastic Syndromes - Lymphoma - Multiple Myeloma - Leukemia, Myelomonocytic, Chronic
Location: Seattle, Washington
- Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery
Conditions: Malignant Mesothelioma
Location: Bellingham, Washington
- Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery
Conditions: Malignant Mesothelioma
Location: Bremerton, Washington
- Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery
Conditions: Malignant Mesothelioma
Location: Mt. Vernon, Washington
- Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery
Conditions: Malignant Mesothelioma
Location: Poulsbo, Washington
- Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery
Conditions: Malignant Mesothelioma
Location: Seattle, Washington
- Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery
Conditions: Malignant Mesothelioma
Location: Seattle, Washington
- Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery
Conditions: Malignant Mesothelioma
Location: Seattle, Washington
- Raltegravir (Isentress/MK-0518) and HIV-1 Infected CD4 Cells During Acute/Early HIV-1
Conditions: Acquired Immunodeficiency Syndrome
Location: Seattle, Washington
- Validating PROMIS Instruments in Back and Leg Pain
Conditions: Leg Pain - Back Pain
Location: Seattle, Washington
- Safety and Effectiveness Study of Ascension's PyroCarbon Radial Head Compared to Ascension's Metal Radial Head
Conditions: Degenerative Arthritis - Post-Traumatic Arthritis - Rheumatoid Arthritis
Location: Seattle, Washington
- Multimedia Educational Program for Patients With Early-Stage Prostate Cancer or Breast Cancer
Conditions: Breast Cancer - Depression - Long-term Effects of Cancer Treatment - Prostate Cancer - Psychosocial Effects of Cancer and Its Treatment
Location: Seattle, Washington
- Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors
Conditions: Adrenocortical Carcinoma - Kidney Cancer - Liver Cancer - Neuroblastoma - Retinoblastoma - Sarcoma
Location: Seattle, Washington
- Study of Weekly ALTU-238 Compared With Daily Nutropin AQ in Prepubertal Children With Growth Hormone Deficiency
Conditions: Growth Hormone Deficiency
Location: Seattle, Washington
- Retapamulin Versus Linezolid in the Treatment of SITL and Impetigo Due to MRSA
Conditions: Impetigo - Secondarily-infected Traumatic Lesions - Skin Diseases, Bacterial
Location: Seattle, Washington
- SmartRisk Stroke Prediction by MRI of Carotid Disease
Conditions: Atherosclerotic Disease, Carotid
Location: Seattle, Washington
- Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma
Conditions: Brain and Central Nervous System Tumors
Location: Bellingham, Washington
- Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sar
Conditions: Sarcoma
Location: Seattle, Washington
- Fludarabine Phosphate and Total-Body Irradiation Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Acute Lymphoblastic
Conditions: Adult Acute Lymphoblastic Leukemia in Remission - Blastic Phase Chronic Myelogenous Leukemia - Childhood Acute Lymphoblastic Leukemia in Remission - Chronic Myelogenous Leukemia, BCR-ABL1 Positive - Chronic Phase Chronic Myelogenous Leukemia - Philadelphi
Location: Seattle, Washington
- Fludarabine Phosphate and Total-Body Irradiation Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Acute Lymphoblastic
Conditions: Adult Acute Lymphoblastic Leukemia in Remission - Blastic Phase Chronic Myelogenous Leukemia - Childhood Acute Lymphoblastic Leukemia in Remission - Chronic Myelogenous Leukemia, BCR-ABL1 Positive - Chronic Phase Chronic Myelogenous Leukemia - Philadelphi
Location: Seattle, Washington
- Donor Lymphocyte Infusion in Treating Patients With Persistent, Relapsed, or Progressing Cancer After Donor Hematopoietic Cell Transplant
Conditions: Accelerated Phase Chronic Myelogenous Leukemia - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Adult Acute Myeloid Leukemia With Del(5q) - Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) - Adult Acute Myeloid Leukemia With t(15;17)(q22;
Location: Seattle, Washington
- Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell Transplant
Conditions: Accelerated Phase Chronic Myelogenous Leukemia - Adult Acute Lymphoblastic Leukemia in Remission - Adult Acute Myeloid Leukemia in Remission - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Adult Acute Myeloid Leukemia With Del(5q) - Adult
Location: Seattle, Washington
- Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Total Body Irradiation, and Donor Stem Cell Transplant Followed By Cyclosporine and Mycop
Conditions: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Adult Acute Myeloid Leukemia With Del(5q) - Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) - Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) - Adult Acute Myeloid Leukemia With t(16;16)
Location: Seattle, Washington
- Triptorelin for Ovary Protection in Childhood Onset Lupus
Conditions: Systemic Lupus Erythematosus
Location: Seattle, Washington
- Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma
Conditions: Sarcoma
Location: Seattle, Washington
- Cidofovir in Renal Transplant Recipients With BKVN
Conditions: BK Virus (Nephropathy)
Location: Seattle, Washington
- Melphalan and Amifostine Followed By One or Two Autologous or Syngeneic Stem Cell Transplants and Maintenance Therapy in Treating Patients With Stage
Conditions: Refractory Multiple Myeloma - Stage II Multiple Myeloma - Stage III Multiple Myeloma
Location: Seattle, Washington
- Melphalan and Amifostine Followed By One or Two Autologous or Syngeneic Stem Cell Transplants and Maintenance Therapy in Treating Patients With Stage
Conditions: Refractory Multiple Myeloma - Stage II Multiple Myeloma - Stage III Multiple Myeloma
Location: Seattle, Washington
- Longitudinal Study of Urea Cycle Disorders
Conditions: Brain Diseases, Metabolic, Inborn - Amino Acid Metabolism, Inborn Errors - Urea Cycle Disorders
Location: Seattle, Washington
- Thymectomy Trial in Non-Thymomatous Myasthenia Gravis Patients Receiving Prednisone Therapy
Conditions: Myasthenia Gravis
Location: Seattle, Washington
- Multicenter Selective Lymphadenectomy Trial II (MSLT-II)
Conditions: Melanoma
Location: Seattle, Washington
- Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor
Conditions: Adrenocortical Carcinoma
Location: Seattle, Washington
- Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
Conditions: Prostate Cancer
Location: Kirkland, Washington
- Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
Conditions: Prostate Cancer
Location: Seattle, Washington
- Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
Conditions: Prostate Cancer
Location: Seattle, Washington
- Rare Genetic Disorders of the Breathing Airways
Conditions: Kartagener Syndrome - Cystic Fibrosis - Pseudohypoaldosteronism - Primary Ciliary Dyskinesia
Location: Seattle, Washington
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Lung Cancer
Location: Anacortes, Washington
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Lung Cancer
Location: Bellingham, Washington
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Lung Cancer
Location: Bremerton, Washington
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Lung Cancer
Location: Kirkland, Washington
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Lung Cancer
Location: Mount Vernon, Washington
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Lung Cancer
Location: Poulsbo, Washington
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Lung Cancer
Location: Seattle, Washington
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Lung Cancer
Location: Seattle, Washington
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Lung Cancer
Location: Seattle, Washington
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Lung Cancer
Location: Seattle, Washington
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Lung Cancer
Location: Sedro-Woolley, Washington
- Fludarabine-based Conditioning for Severe Aplastic Anemia
Conditions: Anemia, Aplastic
Location: Seattle, Washington
- Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroect
Conditions: Brain and Central Nervous System Tumors
Location: Seattle, Washington
- Sorafenib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia
Conditions: Leukemia - Unspecified Childhood Solid Tumor, Protocol Specific
Location: Seattle, Washington
- A Pilot Study to Evaluate the Co-Infusion of Ex Vivo Expanded Cord Blood Cells With an Unmanipulated Cord Blood Unit in Patients Undergoing Cord Blood
Conditions: Accelerated Phase Chronic Myelogenous Leukemia - Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome - Adult Acute Lymphoblastic Leukemia in Remission - Adult Acute Myeloid Leukemia in Remission - Adult Acute Myeloid Leuk
Location: Seattle, Washington
- Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed By Donor Bone Marrow Transplant, Cyclophosphamide, Mycophenolate Mofetil,
Conditions: Nonneoplastic Condition
Location: Seattle, Washington
- Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms Tumor
Conditions: Kidney Cancer - Metastatic Cancer
Location: Seattle, Washington
- Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrom
Conditions: Atypical Chronic Myeloid Leukemia, BCR-ABL Negative - Childhood Myelodysplastic Syndromes - Chronic Myelomonocytic Leukemia - de Novo Myelodysplastic Syndromes - Essential Thrombocythemia - Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable - Phi
Location: Seattle, Washington
- PROLIEVE® Post-Marketing Study TREATMENT OF BENIGN PROSTATIC HYPERPLASIA (BPH)
Conditions: Benign Prostatic Hyperplasia (BPH)
Location: Mountlake Terrace, Washington
- Cisplatin and Radiation Therapy With or Without Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Head and Neck Cancer
Conditions: Stage III Squamous Cell Carcinoma of the Hypopharynx - Stage III Squamous Cell Carcinoma of the Larynx - Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity - Stage III Squamous Cell Carcinoma of the Nasopharynx - Stage III Squamous Cell Carcinom
Location: Seattle, Washington
- Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus
Conditions: Diabetes Mellitus, Type 1
Location: Seattle, Washington
- Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
Conditions: Prostate Cancer
Location: Kirkland, Washington
- Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
Conditions: Prostate Cancer
Location: Seattle, Washington
- Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
Conditions: Prostate Cancer
Location: Seattle, Washington
- Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant, Mycophenolate Mofetil, and Cyclosporine
Conditions: Adult Acute Myeloid Leukemia in Remission - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Adult Acute Myeloid Leukemia With Del(5q) - Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) - Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)
Location: Seattle, Washington
- A Study to Test the Use of Duloxetine for Pain in MS
Conditions: Multiple Sclerosis
Location: Kirkland, Washington
- Contingency Management for Smoking Cessation Among Veterans With Psychotic Disorders
Conditions: Nicotine Dependence - Psychotic Disorders
Location: Seattle, Washington
- Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast Cancer
Conditions: Inflammatory Breast Cancer - Male Breast Cancer - Stage II Breast Cancer - Stage IIIA Breast Cancer - Stage IIIB Breast Cancer - Stage IIIC Breast Cancer
Location: Mt. Vernon, Washington
- Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast Cancer
Conditions: Inflammatory Breast Cancer - Male Breast Cancer - Stage II Breast Cancer - Stage IIIA Breast Cancer - Stage IIIB Breast Cancer - Stage IIIC Breast Cancer
Location: Port Angeles, Washington
- Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast Cancer
Conditions: Inflammatory Breast Cancer - Male Breast Cancer - Stage II Breast Cancer - Stage IIIA Breast Cancer - Stage IIIB Breast Cancer - Stage IIIC Breast Cancer
Location: Seattle, Washington
- THE PARTNER TRIAL: Placement of AoRTic TraNscathetER Valve Trial
Conditions: Critical Aortic Stenosis
Location: Seattle, Washington
- A Study of the Safety and Tolerability of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis
Conditions: Parkinson's Disease Psychosis
Location: Kirkland, Washington
- Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
Conditions: Leukemia
Location: Anacortes, Washington
- Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
Conditions: Leukemia
Location: Bellingham, Washington
- Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
Conditions: Leukemia
Location: Bremerton, Washington
- Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
Conditions: Leukemia
Location: Mount Vernon, Washington
- Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
Conditions: Leukemia
Location: Poulsbo, Washington
- Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
Conditions: Leukemia
Location: Seattle, Washington
- Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
Conditions: Leukemia
Location: Seattle, Washington
- Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
Conditions: Leukemia
Location: Seattle, Washington
- Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
Conditions: Leukemia
Location: Sedro-Woolley, Washington
- Epilepsy Phenome/Genome Project
Conditions: Epilepsy - Localization-related Epilepsy - Infantile Spasms - Lennox-Gastaut Syndrome - Polymicrogyria - Periventricular Heterotopias
Location: Seattle, Washington
- Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed By a Donor Stem Cell Transplant in Treating Patients With Immunodeficiency or
Conditions: Precancerous Condition
Location: Seattle, Washington
- Octreotide and Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
Conditions: Neuroendocrine Carcinoma
Location: Anacortes, Washington
- Octreotide and Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
Conditions: Neuroendocrine Carcinoma
Location: Bellingham, Washington
- Octreotide and Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
Conditions: Neuroendocrine Carcinoma
Location: Bremerton, Washington
- Octreotide and Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
Conditions: Neuroendocrine Carcinoma
Location: Kirkland, Washington
- Octreotide and Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
Conditions: Neuroendocrine Carcinoma
Location: Mount Vernon, Washington
- Octreotide and Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
Conditions: Neuroendocrine Carcinoma
Location: Poulsbo, Washington
- Octreotide and Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
Conditions: Neuroendocrine Carcinoma
Location: Seattle, Washington
- Octreotide and Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
Conditions: Neuroendocrine Carcinoma
Location: Seattle, Washington
- Octreotide and Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
Conditions: Neuroendocrine Carcinoma
Location: Seattle, Washington
- Octreotide and Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
Conditions: Neuroendocrine Carcinoma
Location: Seattle, Washington
- Octreotide and Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
Conditions: Neuroendocrine Carcinoma
Location: Seattle, Washington
- Octreotide and Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
Conditions: Neuroendocrine Carcinoma
Location: Sedro-Woolley, Washington
- Analyzing Gene Regions That May Interact With the Effectiveness of High Blood Pressure Drugs
Conditions: Myocardial Infarction - Cerebrovascular Accident - Death, Sudden, Cardiac
Location: Seattle, Washington
- Bortezomib, Ifosfamide, Carboplatin, and Etoposide, With or Without Rituximab, in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgk
Conditions: Lymphoma
Location: Seattle, Washington
- Efficacy of Electrical Stimulation for Dysphagia in Head & Neck Cancer Patients
Conditions: Dysphagia
Location: Seattle, Washington
- A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Conditions: Psychotic Depression - Major Depression With Psychotic Features - Psychosis
Location: Kirkland, Washington
- Improving Outcomes Assessment in Chronic GVHD
Conditions: Chronic Graft Versus Host Disease
Location: Seattle, Washington
- Closure of Muscular Ventricular Septal Defects (VSDs) With the AMPLATZER Muscular VSD (MuVSD) Occluder - Post Approval Study
Conditions: Ventricular Septal Defects
Location: Seattle, Washington
- Evaluating the Effectiveness of Prednisone, Azathioprine, and N-acetylcysteine in People With Idiopathic Pulmonary Fibrosis
Conditions: Pulmonary Fibrosis
Location: Seattle, Washington
- HCRN Core Data Project: Characterizing Patient Populations in the Hydrocephalus Clinical Research Network (HCRN)
Conditions: Pediatric Hydrocephalus
Location: Seattle, Washington
- The Pediatric Anesthesia Quality Improvement Project
Conditions: Surgery - Anesthesia - Children
Location: Seattle, Washington
- Panobinostat (LBH589) and Imatinib Mesylate in Treating Patients With Previously Treated Chronic Phase Chronic Myelogenous Leukemia
Conditions: Leukemia
Location: Seattle, Washington
- Nilotinib and Imatinib Mesylate After Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemi
Conditions: Accelerated Phase Chronic Myelogenous Leukemia - Adult Acute Lymphoblastic Leukemia in Remission - Blastic Phase Chronic Myelogenous Leukemia - Childhood Acute Lymphoblastic Leukemia in Remission - Childhood Chronic Myelogenous Leukemia - Chronic Myelogen
Location: Seattle, Washington
- Carmustine, Etoposide, Cytarabine, Melphalan, and Antithymocyte Globulin Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With A
Conditions: Autoimmune Disorder
Location: Seattle, Washington
- Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematologic Disease
Conditions: Accelerated Phase Chronic Myelogenous Leukemia - Adult Acute Lymphoblastic Leukemia in Remission - Adult Acute Myeloid Leukemia in Remission - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Adult Acute Myeloid Leukemia With Del(5q) - Adult
Location: Seattle, Washington
- Unrelated Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer
Conditions: Accelerated Phase Chronic Myelogenous Leukemia - Adult Acute Lymphoblastic Leukemia in Remission - Adult Acute Myeloid Leukemia in Remission - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)
Location: Seattle, Washington
- Unrelated Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer
Conditions: Accelerated Phase Chronic Myelogenous Leukemia - Adult Acute Lymphoblastic Leukemia in Remission - Adult Acute Myeloid Leukemia in Remission - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)
Location: Seattle, Washington
- Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab Followed By Bevacizumab and Erlotinib Hydrochloride in Treating Patients With M
Conditions: Estrogen Receptor-negative Breast Cancer - HER2-negative Breast Cancer - Progesterone Receptor-negative Breast Cancer - Stage IV Breast Cancer - Triple-negative Breast Cancer
Location: Kirkland, Washington
- Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab Followed By Bevacizumab and Erlotinib Hydrochloride in Treating Patients With M
Conditions: Estrogen Receptor-negative Breast Cancer - HER2-negative Breast Cancer - Progesterone Receptor-negative Breast Cancer - Stage IV Breast Cancer - Triple-negative Breast Cancer
Location: Mount Vernon, Washington
- Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab Followed By Bevacizumab and Erlotinib Hydrochloride in Treating Patients With M
Conditions: Estrogen Receptor-negative Breast Cancer - HER2-negative Breast Cancer - Progesterone Receptor-negative Breast Cancer - Stage IV Breast Cancer - Triple-negative Breast Cancer
Location: Mount Vernon, Washington
- Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab Followed By Bevacizumab and Erlotinib Hydrochloride in Treating Patients With M
Conditions: Estrogen Receptor-negative Breast Cancer - HER2-negative Breast Cancer - Progesterone Receptor-negative Breast Cancer - Stage IV Breast Cancer - Triple-negative Breast Cancer
Location: Seattle, Washington
- Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab Followed By Bevacizumab and Erlotinib Hydrochloride in Treating Patients With M
Conditions: Estrogen Receptor-negative Breast Cancer - HER2-negative Breast Cancer - Progesterone Receptor-negative Breast Cancer - Stage IV Breast Cancer - Triple-negative Breast Cancer
Location: Seattle, Washington
- A Multi-site Randomized Controlled Trial Comparing Regional and General Anesthesia for Effects on Neurodevelopmental Outcome and Apnea in Infants
Conditions: Inguinal Hernia
Location: Seattle, Washington
- Prostate Active Surveillance Study
Conditions: Prostatic Neoplasms
Location: Seattle, Washington
- Amantadine for the Treatment of Traumatic Brain Injury Irritability and Aggression: A Multi-site Study
Conditions: Brain Injury - Aggression
Location: Seattle, Washington
- Everolimus (RAD001) for Children With Chemotherapy-Refractory Progressive or Recurrent Low-Grade Gliomas
Conditions: Glioma - Low-grade Glioma
Location: Seattle, Washington
- Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation, and Donor Bone Marrow Transplant Followed by Donor Natural Killer Cell Therapy, Mycop
Conditions: Adult Acute Lymphoblastic Leukemia in Remission - Adult Acute Myeloid Leukemia in Remission - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Adult Acute Myeloid Leukemia With Del(5q) - Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) - Ad
Location: Seattle, Washington
- Vaccine Therapy in Treating Patients With Stage IV Breast Cancer
Conditions: HER2-positive Breast Cancer - Male Breast Cancer - Recurrent Breast Cancer - Stage IV Breast Cancer
Location: Seattle, Washington
- Autologous or Syngeneic Stem Cell Transplant Followed by Donor Stem Cell Transplant and Bortezomib in Treating Patients With Newly Diagnosed High-Risk
Conditions: Refractory Multiple Myeloma - Stage I Multiple Myeloma - Stage II Multiple Myeloma - Stage III Multiple Myeloma
Location: Seattle, Washington
- Prediction of Post-Cesarean Section Pain
Conditions: Postoperative Pain
Location: Seattle, Washington
- Chronic Plaque Psoriasis (Ps) Registry
Conditions: Chronic Plaque Psoriasis
Location: Bellingham, Washington
- Chronic Plaque Psoriasis (Ps) Registry
Conditions: Chronic Plaque Psoriasis
Location: Seattle, Washington
- Chronic Plaque Psoriasis (Ps) Registry
Conditions: Chronic Plaque Psoriasis
Location: Seattle, Washington
- Post-Approval Clinical Study of the Talent Thoracic Stent Graft to Treat Thoracic Aortic Aneurysms (THRIVE)
Conditions: Thoracic Aortic Aneurysms
Location: Seattle, Washington
- Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II End
Conditions: Endometrial Cancer - Fatigue - Neurotoxicity
Location: Bellingham, Washington
- Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II End
Conditions: Endometrial Cancer - Fatigue - Neurotoxicity
Location: Bremerton, Washington
- Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II End
Conditions: Endometrial Cancer - Fatigue - Neurotoxicity
Location: Bremerton, Washington
- Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II End
Conditions: Endometrial Cancer - Fatigue - Neurotoxicity
Location: Everett, Washington
- Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II End
Conditions: Endometrial Cancer - Fatigue - Neurotoxicity
Location: Mount Vernon, Washington
- Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II End
Conditions: Endometrial Cancer - Fatigue - Neurotoxicity
Location: Poulsbo, Washington
- Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II End
Conditions: Endometrial Cancer - Fatigue - Neurotoxicity
Location: Seattle, Washington
- Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II End
Conditions: Endometrial Cancer - Fatigue - Neurotoxicity
Location: Seattle, Washington
- Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II End
Conditions: Endometrial Cancer - Fatigue - Neurotoxicity
Location: Seattle, Washington
- Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II End
Conditions: Endometrial Cancer - Fatigue - Neurotoxicity
Location: Seattle, Washington
- Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II End
Conditions: Endometrial Cancer - Fatigue - Neurotoxicity
Location: Seattle, Washington
- Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II End
Conditions: Endometrial Cancer - Fatigue - Neurotoxicity
Location: Seattle, Washington
- Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II End
Conditions: Endometrial Cancer - Fatigue - Neurotoxicity
Location: Seattle, Washington
- Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II End
Conditions: Endometrial Cancer - Fatigue - Neurotoxicity
Location: Sequim, Washington
- A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Conditions: Asthma
Location: Bellingham, Washington
- A Clinical Study to Evaluate Somo•v and Digital Mammography Together as a Breast Cancer Screening Method, Compared to Digital Mammography Alone, in Wo
Conditions: Breast Cancer
Location: Seattle, Washington
- A Study of ARRY-520 in Patients With Relapsed or Refractory Multiple Myeloma
Conditions: Multiple Myeloma - Plasma Cell Leukemia
Location: Seattle, Washington
- Topical Imiquimod and Abraxane in Treating Patients With Advanced Breast Cancer
Conditions: Male Breast Cancer - Recurrent Breast Cancer - Skin Metastases - Stage IV Breast Cancer
Location: Seattle, Washington
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Anacortes, Washington
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Bellingham, Washington
|